-
Aug 20, 2024 | 
jdsupra.com | Julian Polaris
This overview is excerpted from Manatt on Health, Manatt’s subscription service that provides in-depth insights and analysis focused on the legal, policy and market developments. On August 8, a coalition of 15 state attorneys general1 sued CMS in the North Dakota federal court seeking to overturn a May 2024 CMS final rule making Deferred Action for Childhood Arrivals (DACA) recipients eligible for premium tax credits on the Marketplace.
-
Jun 25, 2024 | 
mondaq.com | Helen R. Pfister |Julian Polaris
This paper was written in collaboration with Amanda Eiden,
Anthony DiFranzo, Matthew Itzkowitz, and Alexandra Bhatti.
This is an excerpt from a recently published study in AJMP
Focus, "State Medicaid Coverage and Reimbursement of Adult
Vaccines Administered by Physicians and Pharmacists as of
2022", which was supported by Merck. Click here to read the full article.
-
Jun 24, 2024 | 
mondaq.com | Helen R. Pfister |Julian Polaris
This is an excerpt from a recently published study in AJMP
Focus, "State Medicaid Coverage and Reimbursement of Adult
Vaccines Administered by Physicians and Pharmacists as of
2022", which was supported by Merck. Click here to read the full
article.
Effective October 2023, federal law requires Medicaid programs
to cover all recommended adult vaccines administered by physicians
with no cost sharing for all eligibility groups. However, uniform
coverage does not always translate to optimal uptake.
-
Jun 7, 2023 | 
mondaq.com | Helen R. Pfister |Julian Polaris |Matthew Itzkowitz
Editor's Note: In a new white paper funded by Pfizer, Inc.,
Manatt Health discusses the current landscape of Medicaid and
Children's Health Insurance Program (CHIP) coverage and
reimbursement for prenatal vaccines, informed by a recent
assessment of relevant policies in all 50 states, plus Washington,
D.C., and Puerto Rico.
-
Jun 6, 2023 | 
jdsupra.com | Matthew Itzkowitz |Helen R. Pfister |Julian Polaris
Editor’s Note: In a new white paper funded by Pfizer, Inc., Manatt Health discusses the current landscape of Medicaid and Children’s Health Insurance Program (CHIP) coverage and reimbursement for prenatal vaccines, informed by a recent assessment of relevant policies in all 50 states, plus Washington, D.C., and Puerto Rico.
-
May 26, 2023 | 
mondaq.com | Helen R. Pfister |Julian Polaris |Matthew Itzkowitz
Prenatal vaccines—those administered during a
pregnancy—provide crucial protections to pregnant women
and/or newborns against communicable diseases such as whooping
cough and influenza. Additional prenatal vaccines are in the
pipeline, including a vaccine against infant respiratory syncytial
virus (RSV).
Despite the demonstrated effectiveness of prenatal vaccines,
fewer than one out of four pregnant women receives all federally
recommended vaccines.
-
May 18, 2023 | 
jdsupra.com | Matthew Itzkowitz |Helen R. Pfister |Julian Polaris
Prenatal vaccines provide important protection for pregnant women and newborns against communicable diseases such as whooping cough and influenza. However, fewer than one out of four pregnant women receives all federally recommended vaccines during their pregnancy. Moreover, vaccination rates are lower among pregnant people covered by Medicaid and the Children’s Health Insurance Program (CHIP) than among people with private health insurance.
-
May 17, 2023 | 
jdsupra.com | Matthew Itzkowitz |Helen R. Pfister |Julian Polaris
Prenatal vaccines—those administered during a pregnancy—provide crucial protections to pregnant women and/or newborns against communicable diseases such as whooping cough and influenza. Additional prenatal vaccines are in the pipeline, including a vaccine against infant respiratory syncytial virus (RSV).
Please see Publication below for more information.
Download PDF
-
Apr 5, 2023 | 
jdsupra.com | Michael R Kolber |Julian Polaris
The Affordable Care Act (ACA) requirement for commercial coverage of certain preventive services without cost sharing is unenforceable, according to a March 30 decision in Braidwood Management, Inc. v. Becerra by Judge Reed O’Connor in the U.S. District Court, Northern District of Texas.
-
Jan 20, 2023 | 
healthaffairs.org | Alexandra Bhatti |Amanda Eiden |Anthony DiFranzo |Julian Polaris |Helen R. Pfister |Matthew Itzkowitz
Signed on August 16, 2022, the Inflation Reduction Act (IRA) addresses longstanding vaccine cost barriers by guaranteeing coverage for routine vaccinations, without cost sharing, for all adults enrolled in Medicaid and Medicare. Once these coverage barriers are removed, approximately 9 out of 10 Americans will have access to vaccines at no cost. However, policy makers must not stop there in their efforts to improve adult vaccination rates.
